George Mason University researchers target breast cancer in three trials
A malarial drug is showing promise in stopping breast cancer before it starts, Mason researchers are discovering during a clinical trial.
Nov 1, 2012
0
0
A malarial drug is showing promise in stopping breast cancer before it starts, Mason researchers are discovering during a clinical trial.
Nov 1, 2012
0
0
Among postmenopausal women with normal body mass index (BMI), those with higher body fat levels had an increased risk for invasive breast cancer, according to data presented at the American Association for Cancer Research ...
Jan 26, 2018
0
15
Treatment with the chemotherapy agent capecitabine increased disease-free survival for women with HER2-negative breast cancer that was not eliminated by presurgery chemotherapy, according to results from the phase III CREATE-X ...
Dec 9, 2015
0
0
High levels of vitamin D are associated with protection against bladder cancer, according to a multidisciplinary study coordinated by molecular biologists and epidemiologists from the Spanish National Cancer Research Centre ...
Oct 30, 2012
0
0
(HealthDay)—Accelerated partial breast irradiation (APBI) yields five-year clinical outcomes and patterns of failure similar to those achieved with whole breast irradiation (WBI), with excellent three-year survival for ...
Aug 24, 2012
0
0
Understanding how the protein km23-1 enables in the spread of colon cancer may lead to new treatments for the disease, according to researchers at Penn State College of Medicine.
Jun 27, 2013
0
0
(HealthDay)—For patients undergoing left colon and rectal cancer resections, the addition of oral antibiotics to mechanical bowel preparation (MBP) is associated with a reduced rate of surgical site infections (SSIs), according ...
Oct 19, 2017
0
0
(HealthDay)—For women undergoing wire-guided breast conserving surgery (BCS) for nonpalpable breast lesions, the risk of reoperation is higher for those with ductal carcinoma in situ (DCIS) than those with invasive breast ...
Dec 29, 2016
0
0
A protein called retinitis pigmentosa GTPase regulator interacting protein 1-like (RPGRIP1L) performs various functions that are important for development and for health throughout life, and mutations in the RPGRIP1L gene ...
May 15, 2024
0
0
A panel of 55 genes, almost all of which are impacted by the loss of a particular protein, appears to predict if breast cancer will become invasive, leading to poorer survival, researchers at Georgetown Lombardi Comprehensive ...
Feb 11, 2014
0
0